Observational, Safety Study of NovoNorm® (Repaglinide) and Insulin Analogue Combination Therapy in Type 2 Diabetes in Korea

Clinical trial NCT01355718 · COMPLETED

Trial details

NCT number: NCT01355718
Sponsor: Novo Nordisk A/S
Status: COMPLETED
Study type: OBSERVATIONAL

Diabetes Diabetes Mellitus, Type 2

Start date: 2011-08-01
Primary completion: 2013-03-01
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.